Skip to main content

#160687

HEK293-CEACAM1-Fc cell line

Cat. #160687

HEK293-CEACAM1-Fc cell line

Cat. #: 160687

Sub-type: Continuous

Unit size: 1x10^6 cells / vial

Availability: 10-12 weeks

Organism: Human

Tissue: Kidney

Model: Transgenic

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Bernhard Singer

Institute: LeukoCom

Tool Details
Target Details
Handling

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: HEK293-CEACAM1-Fc cell line
  • Alternate name: Carcinoembryonic antigen-related cell adhesion molecule 1, CD66a, Cluster of Differentiation 66a
  • Research fields: Cancer;Cell biology;Immunology
  • Tool sub type: Continuous
  • Parental cell: HEK293
  • Organism: Human
  • Tissue: Kidney
  • Growth properties: Adherent
  • Model: Transgenic
  • Conditional: No
  • Description: CEACAM-1, also known as CD66a, is an immunoglobulin superfamily protein that is expressed on neutrophils, activated NK cells, bile duct and colonic epithelial cells, and endothelial cells. CEACAM-1 is heavily glycosylated and carries high mannose residues and (sialyl) Lewis-x. It is expressed as at least three soluble and seven transmembrane isoforms, with variations occurring in both the ECD and cytoplasmic region. It engages in homotypic adhesion and heterotypic adhesion with CEACAM-3/CD66d...
  • Production details: Overexpression of human CEACAM1-Fc Chimera Protein
  • Recommended controls: HEK293 parental line

Target Details

  • Target: CEACAM1

Handling

  • Format: Frozen
  • Growth medium: DMEM + 10% FBS
  • Unit size: 1x10^6 cells / vial
  • Shipping conditions: Dry ice

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.